J. Rotschafer

American Journal of Health-System Pharmacy · 2009–2020

A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from J. Rotschafer's perspective

Ordered by how strongly the researchers J. Rotschafer trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections (Clinical Pharmacokinetics)
  2. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of… (American Journal of Health-System Pharmacy)
  3. Antimicrobial pharmacodynamics: critical interactions of 'bug and drug' (Nature Reviews Microbiology)
  4. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. (Archives of Internal Medicine)
  5. Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia (Journal of Clinical Microbiology)
  6. Autoinduction and signal transduction in the regulation of staphylococcal virulence (Molecular Microbiology)
  7. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. (Clinical Infectious Diseases)
  8. Prevalence of Obesity Among Adults and Youth: United States, 2015-2016. (NCHS data brief)
  9. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. (Chest)
  10. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. (New England Journal of Medicine)

Their papers